NCT02695381

Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness

A Randomized, Double-blind, Multiple-dose, Placebo-controlled Study to Evaluate the Efficacy and Safety of Etodolac-lidocaine Patch Applied Once Daily in Subjects Experiencing Acute Delayed Onset Muscle Soreness

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: MEDRx USA, Inc. · Industry
• Sex: All
• Age: 18 Years – 35 Years
• Healthy volunteers: Accepted

Summary

This study evaluate the efficacy and safety of Etodolac-lidocaine topical patch applied one time daily when compared with placebo in the treatment of acute Delayed Onset Muscle Soreness (DOMS) of the upper limbs.

Conditions

• Acute Delayed Onset Muscle Soreness (DOMS)

Interventions

Type	Name	Description
DRUG	Etodolac-lidocaine topical patch	Once daily
DRUG	Placebo	Once daily

Timeline

• Start date: 2016-03-01
• Primary completion: 2016-08-01
• Completion: 2016-09-01
• First posted: 2016-03-01
• Last updated: 2016-09-12

Locations

1 site across 1 country: United States